CANF
Can-Fite Biopharma
$3.15
−$0.04 (−1.25%)Jul 27, 2026
Key metrics
The numbers that frame CANF today
- Market cap
- $4.12M
- P/E (TTM)
- -0.4
- EV / FCF
- 0.1
- Gross margin
- 100%
- EV / Sales
- -3.3
- ROIC
- -535.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.56
- 52wk High
- $20.20
Growth
Revenue and earnings trend for CANF
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CANF
Is Can-Fite Biopharma a good buy?
No. Can-Fite Biopharma has poor quality and poor momentum. Both signals point to a weaker setup.
What is the market capitalization of CANF?
Can-Fite Biopharma's market capitalization is $4.12M.
What is the P/E ratio for CANF stock?
Can-Fite Biopharma's current P/E ratio is -0.4.
What is the 52-week high for CANF stock?
The 52-week high for Can-Fite Biopharma is $20.20. The current close of $3.15 is 84.4% below that high.
What is the 52-week low for CANF stock?
The 52-week low for Can-Fite Biopharma is $2.56. The current close of $3.15 is 23% above that low.
Does CANF stock pay dividends?
Can-Fite Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CANF?
Can-Fite Biopharma's Debt / Equity ratio is 0.01.